Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
- PMID: 8402893
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
Abstract
Hereditary major histocompatibility complex (MHC) class II deficiency (or bare lymphocyte syndrome) is a form of severe primary immunodeficiency with a total lack of MHC class II expression. It is due to a defect in the regulation of MHC class II genes. A novel gene was isolated by complementation cloning, using an MHC class II-negative mutant cell line. This gene (CIITA) functions as a transactivator of MHC class II gene expression and restores expression of all MHC class II isotypes in mutant cells. In addition, CIITA fully corrects the MHC class II regulatory defect of cells from patients with bare lymphocyte syndrome. In this disease we have identified a splicing mutation that results in a 24 amino acid deletion in CIITA, resulting in loss of function of the transactivator. Hence, the CIITA gene is essential for MHC class II gene expression and has been shown to be responsible for hereditary MHC class II deficiency.
Similar articles
-
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.Eur J Immunol. 1996 Oct;26(10):2456-60. doi: 10.1002/eji.1830261028. Eur J Immunol. 1996. PMID: 8898960
-
Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.Immunogenetics. 2002 Feb;53(10-11):821-9. doi: 10.1007/s00251-001-0395-7. Epub 2002 Jan 29. Immunogenetics. 2002. PMID: 11862382
-
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993.J Immunol. 2007 Jun 1;178(11):6677-88. J Immunol. 2007. PMID: 17513710 No abstract available.
-
Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.Tissue Antigens. 2006 Mar;67(3):183-97. doi: 10.1111/j.1399-0039.2006.00557.x. Tissue Antigens. 2006. PMID: 16573555 Review.
-
Combined immunodeficiency with defective expression in MHC class II genes.Immunodefic Rev. 1989;1(2):135-53. Immunodefic Rev. 1989. PMID: 2517209 Review.
Cited by
-
The intrinsically disordered transcriptional activation domain of CIITA is functionally tuneable by single substitutions: An exception or a new paradigm?Protein Sci. 2024 Feb;33(2):e4863. doi: 10.1002/pro.4863. Protein Sci. 2024. PMID: 38073129
-
A Ménage à trois: NLRC5, immunity, and metabolism.Front Immunol. 2024 Jul 5;15:1426620. doi: 10.3389/fimmu.2024.1426620. eCollection 2024. Front Immunol. 2024. PMID: 39035010 Free PMC article. Review.
-
Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA.J Clin Immunol. 2004 Jan;24(1):97-106. doi: 10.1023/B:JOCI.0000018068.37899.6d. J Clin Immunol. 2004. PMID: 14997039
-
CARD-only proteins regulate in vivo inflammasome responses and ameliorate gout.Cell Rep. 2023 Mar 28;42(3):112265. doi: 10.1016/j.celrep.2023.112265. Epub 2023 Mar 16. Cell Rep. 2023. PMID: 36930645 Free PMC article.
-
CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.Mol Cell Biol. 2010 Sep;30(17):4211-23. doi: 10.1128/MCB.00327-10. Epub 2010 Jun 28. Mol Cell Biol. 2010. PMID: 20584980 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials